Ischaemic heart disease (IHD), also referred to as coronary artery disease (CAD), describes a state in which myocardial oxygen supply is insufficient to meet myocardial metabolic demand.
At face value, that is a simple supply–demand mismatch. In reality, it reflects a complex, progressive, inflammatory disease of the coronary arteries that evolves over decades before becoming clinically apparent.
The heart extracts a very high proportion of oxygen from coronary blood at rest. Unlike skeletal muscle, it cannot simply extract much more when demand rises. When the myocardium needs more oxygen — during exercise, stress, tachycardia — the only way to meet that demand is to increase coronary blood flow.
Anything that limits the ability of coronary arteries to increase flow becomes clinically important.
To understand IHD properly, we need to follow the biology.


